Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.

 

Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
   
Paper Publishing WeChat
Book Publishing WeChat
(or Email:book@scirp.org)

Article citations

More>>

Nappi, R.E., Biglia, N., Cagnacci, A., Di Carlo, C., Luisi, S. and Paoletti, A.M. (2016) Diagnosis and Management of Symptoms Associated with Vulvovaginal Atrophy: Expert Opinion on Behalf of the Italian VVA Study Group. Gynecological Endocrinology, 32, 602-606.
https://doi.org/10.1080/09513590.2016.1183627

has been cited by the following article:

  • TITLE: Solid State Vaginal Laser for the Treatment of Genitourinary Syndrome of Menopause: A Preliminary Report

    AUTHORS: D. Dodero, F. Frascani, M. Angelucci, G. Bernabei, E. Merlo, F. Locatelli, F. Murina

    KEYWORDS: Atrophic Vaginitis, Genitourinary Syndrome of Menopause, Urinary Incontinence, Fractional Laser

    JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.8 No.2, February 9, 2018

    ABSTRACT: Background: Genitourinary syndrome of menopause (GSM) is the new term for vulvovaginal atrophy (VVA). The condition is relevant in more than 50% of women, having an adverse impact on quality of life and sexual relationships. Objective: To assess the efficacy and safety of a new type of non-ablative laser, Solid State Vaginal Laser (SSVL), for vaginal tissue regeneration and rejuvenation. Method: Eighty participants with GSM symptoms were treated with a total of 4 treatments in about two months (every 15 - 20 days) of a non-ablative SSVL (LASEmaR 1500TM-EUFOTON). A cumulative intensity of GSM symptoms using a 10-cm VAS (dryness and/or burning and/or dyspareunia), the vaginal health index (VHI), the Female Sexual Function Index (FSFI) were evaluated. Urinary Incontinence Short Form (ICIQ-UI SF) and vaginal bioptic samples were also collected. Results: Improvement following the SSVL was observed on VHIS, VVA symptoms and sexual female function. This finding was also ratified by the improvement of vaginal histological features. After the SSVL treatment, almost all patients (91%) affected by urinary incontinence obtained the complete remission of symptoms. Conclusion: The objective evaluation of VHIS, FSFI and ICIQ-UI SF scores and the histological results indicates a real favorable effect of SSVL on GSM and on urinary incontinence.